53P Claudins Expression in Breast Cancer: High or Low, What to Expect?
نویسندگان
چکیده
منابع مشابه
What to Expect
We study generalisations to the structure groups U(n) of the familiar (abelian) Seiberg-Witten monopole equations on a four-manifold X and their moduli spaces. For n = 1 one obtains the classical monopole equations. For n > 1 our results indicate that there should not be any non-trivial gauge-theoretical invariants which are obtained by the scheme ‘evaluation of cohomology classes on the fundam...
متن کاملChemotherapy of metastatic breast cancer: what to expect in 2001 and beyond.
Chemotherapy plays an important role in the management of metastatic breast cancer. The anthracyclines (doxorubicin, epirubicin) and the taxanes (paclitaxel, docetaxel) are considered the most active agents for patients with advanced breast cancer. Traditionally, the anthracyclines have been used in combination with cyclophosphamide and 5-fluorouracil (FAC, FEC). The taxanes have single-agent a...
متن کاملWhat to expect from teleconferencing.
Like other marvels of the electronic age, teleconferencing has been both oversold and underused. Though it has many potential uses, what managers know, or think they know, about it is generally based on misconceptions. Rather than relying only on vendors of teleconferencing, potential purchasers should first decide what their communication needs are, then choose the system that suits them best....
متن کاملHigh Expression of Sphingosine Kinase 1 in Estrogen and Progesterone Receptors-Negative Breast Cancer
Background & objective: Breast cancer is the leading cause of cancer related death in females. Sphingosine kinase 1 (SPHK1) and its product sphingosine-1-phosphate (S1P) are the essential key regulator molecules in breast cancer through their ability to promote cell proliferation, angiogenesis, cell proliferation, and lymphagiogenesis. SPHK1 i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2012
ISSN: 0923-7534
DOI: 10.1016/s0923-7534(19)65698-x